{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/109591"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/109591","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"The immunomodulatory roles of small heterodimer partner and their implications in breast cancer progression","abstract":"Limited","abstract_html":"Limited","abstract_has_math":false,"creators":["Shahoei, Sayyed Hamed"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Molecular & Integrative Physi","degree_department":null,"school":null,"contributors":["Nelson, Erik R","Anakk, Sayeepriyadarshini","Kim Kemper, Jongsook","Kranz, David M"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021-03-05T21:45:34Z","date_published":"2021-03-05T21:45:34Z","updated_at":"2026-07-22T22:24:50Z","subjects":["SHP"],"languages":["en"],"rights":["Copyright 2020 Sayyed Hamed Shahoei"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/109591","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Nelson, Erik R","Anakk, Sayeepriyadarshini","Kim Kemper, Jongsook","Kranz, David M"]},{"key":"dc:creator","label":"Author","values":["Shahoei, Sayyed Hamed"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2021-03-05T21:45:34Z","2023-03-05T21:47:41Z","2020-11-29","2020-12"]},{"key":"dc:type","label":"Dc Type","values":["text","Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Molecular & Integrative Physi"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["SHP"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2020 Sayyed Hamed Shahoei"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/109591"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Limited","Breast cancer remains the second cancer-related cause of death among women. With limited therapeutic options for metastatic disease, immune checkpoint blockade (ICB) was anticipated to provide a novel treatment strategy. However, the efficacy of ICB in breast cancer has been limited, in part due to the highly immunosuppressive tumor microenvironment (TME); myeloid cells and regulatory T (Treg) cells being known contributors. Nuclear receptors have been implicated in the regulation of myeloid cells. Therefore, we evaluated this superfamily, and found that higher tumoral SHP expression was associated with favorable prognosis for patients. Thus, we hypothesized that SHP modulates the TME to lower breast cancer progression. Using genetic and pharmacological approaches, we evaluated the immune and anti-cancer function of myeloid cell-expressed SHP. We found that SHP within mouse and human myeloid cells skews T cell expansion away from Tregs, resulting in more robust effector T (Teff) cell responses. Furthermore, a small-molecule agonist of SHP, DSHN, lowered Tregs in antigen-tolerized mice. Using the MMTV-PyMT model of mammary cancer, it was found that tumor growth was increased in mice lacking SHP (SHP-/-). Transcriptomic analysis of these tumors indicated an enriched suppressor T cell activity in the absence of SHP. Indeed, flow cytometry analysis indicated increased infiltration of myeloid cells and Tregs, with a concomitant decrease in Teffs. In further support for a role of myeloid cell-expressed SHP, syngeneic mammary cancer grafts grew faster in mice with SHP specifically knocked down in the myeloid lineage (LysMCre;SHPfl/fl). Importantly, treatment of mice with DSHN decreased growth of tumors and metastatic lesions in mice, highlighting the potential clinical translation of these findings. SHP expression within myeloid cells results in decreased expansion of Treg cells, ultimately altering the TME to promote immune anti-cancer activity. Our work reveals a novel mechanism to lower immunosuppression of solid cancers, which will likely enhance the efficacy of standard ICB therapy.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2022-12-01","The student, Sayyed Hamed Shahoei, accepted the attached license on 2020-11-22 at 19:58.","The student, Sayyed Hamed Shahoei, submitted this Dissertation for approval on 2020-11-22 at 20:19.","This Dissertation was approved for publication on 2020-11-29 at 14:07.","DSpace SAF Submission Ingestion Package generated from Vireo submission #15934 on 2021-03-04 at 16:32:13","Made available in DSpace on 2021-03-05T21:45:34Z (GMT). No. of bitstreams: 2 SHAHOEI-DISSERTATION-2020.pdf: 1765599 bytes, checksum: 8dbe44694a8dba06843679e6c6521465 (MD5) LICENSE.txt: 4217 bytes, checksum: bfabbe5ca83c88e66b3d23ae82ff3d11 (MD5) Previous issue date: 2020-11-29","Embargo set by: Seth Robbins for item 117296 Lift date: 2023-03-05T21:45:47Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 117296 Lift date: 2023-03-05T21:47:41Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Author requested closed access (OA after 2yrs) in Vireo ETD system"]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["The immunomodulatory roles of small heterodimer partner and their implications in breast cancer progression"]}]}],"canonical_facts":{"dc:contributor":["Nelson, Erik R","Anakk, Sayeepriyadarshini","Kim Kemper, Jongsook","Kranz, David M"],"dc:creator":["Shahoei, Sayyed Hamed"],"dc:date":["2021-03-05T21:45:34Z","2023-03-05T21:47:41Z","2020-11-29","2020-12"],"dc:description":["Limited","Breast cancer remains the second cancer-related cause of death among women. With limited therapeutic options for metastatic disease, immune checkpoint blockade (ICB) was anticipated to provide a novel treatment strategy. However, the efficacy of ICB in breast cancer has been limited, in part due to the highly immunosuppressive tumor microenvironment (TME); myeloid cells and regulatory T (Treg) cells being known contributors. Nuclear receptors have been implicated in the regulation of myeloid cells. Therefore, we evaluated this superfamily, and found that higher tumoral SHP expression was associated with favorable prognosis for patients. Thus, we hypothesized that SHP modulates the TME to lower breast cancer progression. Using genetic and pharmacological approaches, we evaluated the immune and anti-cancer function of myeloid cell-expressed SHP. We found that SHP within mouse and human myeloid cells skews T cell expansion away from Tregs, resulting in more robust effector T (Teff) cell responses. Furthermore, a small-molecule agonist of SHP, DSHN, lowered Tregs in antigen-tolerized mice. Using the MMTV-PyMT model of mammary cancer, it was found that tumor growth was increased in mice lacking SHP (SHP-/-). Transcriptomic analysis of these tumors indicated an enriched suppressor T cell activity in the absence of SHP. Indeed, flow cytometry analysis indicated increased infiltration of myeloid cells and Tregs, with a concomitant decrease in Teffs. In further support for a role of myeloid cell-expressed SHP, syngeneic mammary cancer grafts grew faster in mice with SHP specifically knocked down in the myeloid lineage (LysMCre;SHPfl/fl). Importantly, treatment of mice with DSHN decreased growth of tumors and metastatic lesions in mice, highlighting the potential clinical translation of these findings. SHP expression within myeloid cells results in decreased expansion of Treg cells, ultimately altering the TME to promote immune anti-cancer activity. Our work reveals a novel mechanism to lower immunosuppression of solid cancers, which will likely enhance the efficacy of standard ICB therapy.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2022-12-01","The student, Sayyed Hamed Shahoei, accepted the attached license on 2020-11-22 at 19:58.","The student, Sayyed Hamed Shahoei, submitted this Dissertation for approval on 2020-11-22 at 20:19.","This Dissertation was approved for publication on 2020-11-29 at 14:07.","DSpace SAF Submission Ingestion Package generated from Vireo submission #15934 on 2021-03-04 at 16:32:13","Made available in DSpace on 2021-03-05T21:45:34Z (GMT). No. of bitstreams: 2 SHAHOEI-DISSERTATION-2020.pdf: 1765599 bytes, checksum: 8dbe44694a8dba06843679e6c6521465 (MD5) LICENSE.txt: 4217 bytes, checksum: bfabbe5ca83c88e66b3d23ae82ff3d11 (MD5) Previous issue date: 2020-11-29","Embargo set by: Seth Robbins for item 117296 Lift date: 2023-03-05T21:45:47Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 117296 Lift date: 2023-03-05T21:47:41Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Author requested closed access (OA after 2yrs) in Vireo ETD system"],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/109591"],"dc:language":["en"],"dc:rights":["Copyright 2020 Sayyed Hamed Shahoei"],"dc:subject":["SHP"],"dc:title":["The immunomodulatory roles of small heterodimer partner and their implications in breast cancer progression"],"dc:type":["text","Thesis"],"thesis:degree_discipline":["Molecular & Integrative Physi"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:50Z"}